FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a method of producing a cocrystalline form of 2,8-dimethyl-5-phenethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole with nicotinic acid of formula II at a molar ratio of 2,8- dimethyl-5-phenethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole and nicotinic acid in a 1:1 cocrystal and the following parameters: orthorhombic cells, C27H29N3O2 at 20°C:
F(000) = 913, unit cell parameters and intensities of 19,604 reflections measured (6.32° ≤ 2Θ ≤ 49.98°), 4002 independent (Rint = 0.1028, Rsigma = 0.0964), final R1 = 0.0625 (I>=2σ (I)) and wR2 = 0.1882, taking into consideration that 2,8-dimethyl-5-phenethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole hydrochloride is treated with equimolar aqueous alkali solution NaOH and the resulting free base 2,8-dimethyl-5-phenethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole is mixed with an equimolar amount of nicotinic acid, Ethyl acetate is added to the mixture as a solvent and subjected to mechanical activation by grinding, followed by evaporation of the solvent residue.
EFFECT: method of obtaining a cocrystalline form of 2,8-dimethyl-5-phenethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole with nicotinic acid which can find its application in medicine for the production of pharmaceuticals for the treatment of neurodegenerative diseases and associated depressive episodes, including in the treatment of Alzheimer's disease.
1 cl, 3 dwg, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
LIGANDS OF ALPHA-ADRENOCEPTORS, DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND USE THEREOF | 2008 |
|
RU2407744C2 |
NORADRENERGIC AND SPECIFICALLY SEROTONERGIC ANXIOLYTIC AND ANTIDEPRESSANT, ITS PRODUCTION AND APPLICATION METHOD | 2020 |
|
RU2775772C2 |
SUBSTITUTED 2,3,4,5-TETRAHYDRO-1N-PYRIDO[4,3-b]INDOLES, METHOD OF OBTAINING THEM AND USE | 2007 |
|
RU2338745C1 |
DERIVATIVES OF HYDROGENATED PYRIDO[4,3-B]INDOLES, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF PATIENT TREATMENT | 1995 |
|
RU2140417C1 |
GEROPROTECTING AGENT BASED ON HYDROGENATED PYRIDO[4,3-b]INDOLES (VARIANTS), PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD FOR ITS USING | 2003 |
|
RU2283108C2 |
SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-PYRIDO[4,3-b]INDOLES, METHOD OF PRODUCTION AND APPLICATION THEREOF | 2007 |
|
RU2334747C1 |
METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA WITH USING ATYPICAL NEUROLEPTIC COMBINED THERAPY | 2007 |
|
RU2508106C2 |
METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA WITH USING NEUROLEPTIC COMBINED THERAPY | 2007 |
|
RU2508096C2 |
DERIVATIVES OF 1,2,3,4-TETRAHYDROPYRIDO[4,3-b]INDOLE-CONTAINING PHENOTHIAZINES AS INHIBITORS OF CHOLINESTERASES AND BLOCKERS OF SEROTONIN RECEPTORS 5-HT, METHODS OF OBTAINING THEIR CHLOROHYDRATES AND BASED ON THEM PHARMACEUTICAL PREPARATION | 2013 |
|
RU2530881C1 |
PHARMACEUTICAL COMPOSITION FOR NEURODEGENERATIVE DISEASES OF HYDROGENATED PYRIDO(4,3-b)INDOLE, METHOD FOR PREPARING AND BASED DRUG | 2009 |
|
RU2428185C1 |
Authors
Dates
2023-10-25—Published
2022-05-15—Filed